Skip to Content

Department of Epidemiology

Xifeng Wu, M.D., Ph.D.
Professor and Chair

The Department’s trans-disciplinary, integrative approach is instrumental in our goal of fostering the highest quality epidemiological research with the purpose of acquiring new knowledge related to endpoints across the cancer continuum – from risk through survivorship. Towards this, our innovative research programs will:

  • Foster the highest quality epidemiologic research to assess the distribution and determinants of cancer with the aim of establishing preventive measures through traditional, molecular, and clinical epidemiology;
  • Promote translational research, including personalized medicine (risk prediction, prevention, and response), pharmacogenetics, improved screening modalities, energy balance, pre-malignant genome atlas, survivorship and quality of life to bridge the gap between epidemiology and clinic and public health applications;
  • Develop and maintain institution-wide epidemiologic data, biospecimens, genomic resources and methodologies to support research initiatives and serving as an institutional resource for epidemiologic consultation, collaboration, and service to connect epidemiology to basic science and clinical research;
  • Nurture a top mentoring and educational program providing training for the next generation of high-quality scientists in cancer risk assessment, prevention, and translational research;
  • Generate community-based prospective research in high-risk and minority/underserved populations and being a magnet for global collaboration.

Cancer of the Lung Evaluation and Assessment of Risk

The CLEAR lung cancer risk prediction tool can quantify a smoker’s risk of developing lung cancer in the next five, 10 or 15 years based on the person’s age, sex, smoking history, medical history, family history of cancer and past exposures to asbestos or wood dust. Information obtained from this risk tool can enable physicians and patients in making decisions about lung cancer screening options.

Learn more about the Cancer of the Lung Evaluation and Assessment of Risk (CLEAR).


© 2014 The University of Texas MD Anderson Cancer Center